With cell manufacturing constrained, investments in storage systems are accelerating. Reliance Industries has put on hold plans to manufacture lithium-ion battery cells in India after failing to ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

Mesenchymal stem/stromal cells (MSCs) have been identified as a promising resource for cell therapies due to their high immunomodulation ability, anti-inflammatory properties, tissue regeneration ...

LONDON--(BUSINESS WIRE)--#automation--Mytos, a biotechnology company automating cell manufacturing, today announced the launch of its automated contract development and manufacturing organization ...